Danaher Co. (NYSE:DHR) Stock Position Decreased by Coastline Trust Co

Coastline Trust Co trimmed its stake in Danaher Co. (NYSE:DHR) by 3.8% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 8,024 shares of the conglomerate’s stock after selling 320 shares during the quarter. Coastline Trust Co’s holdings in Danaher were worth $1,842,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in Danaher by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 59,750,122 shares of the conglomerate’s stock valued at $13,715,641,000 after acquiring an additional 315,912 shares during the period. Geode Capital Management LLC raised its stake in shares of Danaher by 2.4% during the fourth quarter. Geode Capital Management LLC now owns 13,358,206 shares of the conglomerate’s stock valued at $3,056,996,000 after purchasing an additional 315,446 shares in the last quarter. Norges Bank acquired a new stake in Danaher in the fourth quarter worth about $2,130,740,000. Bank of New York Mellon Corp increased its stake in Danaher by 5.4% during the 4th quarter. Bank of New York Mellon Corp now owns 8,589,019 shares of the conglomerate’s stock valued at $1,971,609,000 after buying an additional 441,012 shares during the period. Finally, Fisher Asset Management LLC raised its position in shares of Danaher by 0.6% during the 4th quarter. Fisher Asset Management LLC now owns 4,578,945 shares of the conglomerate’s stock worth $1,051,097,000 after buying an additional 26,305 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Down 2.1 %

Shares of DHR stock opened at $186.71 on Friday. The company has a market capitalization of $133.44 billion, a price-to-earnings ratio of 35.36, a PEG ratio of 2.66 and a beta of 0.86. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The stock’s 50 day simple moving average is $201.99 and its 200 day simple moving average is $227.23. Danaher Co. has a twelve month low of $171.00 and a twelve month high of $281.70.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the prior year, the business posted $2.09 earnings per share. As a group, research analysts predict that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. This is an increase from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date is Friday, March 28th. This represents a $1.28 annualized dividend and a dividend yield of 0.69%. Danaher’s payout ratio is presently 24.24%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the stock. Citigroup reiterated a “buy” rating on shares of Danaher in a research note on Monday, April 7th. Jefferies Financial Group dropped their price objective on Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research note on Wednesday, January 29th. Raymond James restated a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. Wells Fargo & Company lowered their target price on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. Finally, The Goldman Sachs Group raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $260.00 price target for the company in a report on Friday, March 21st. Four analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $274.55.

Insider Activity at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 11.10% of the stock is owned by corporate insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.